Skip to main content
PBSV logo

PBSV · Pharma-Bio Serv, Inc. · Metrics

Track PBSV — free
$0.48 +0.08 (+20.00%) At close · Oct 19
Market Cap
$10.99M
Shares
22.90M
Volume · Oct 19 500 Avg daily vol (3M) 7192

PBSV metrics

84 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.48
Market cap
$10.99M

Price action

20 metrics
Price change (1W)
+0.0%
Price change (30D)
+2.1%
Price change (3M)
-4.0%
Price change (6M)
-4.0%
Price change (YTD)
-20.0%
Price change (1Y)
-21.3%
Trailing year
Price change (5Y)
-52.0%
52-week high
$0.65
52-week low
$0.35
Change from 52-week high
-26.2%
Change from 52-week low
+37.1%
Annualized volatility
192.0%
Annualized volatility (3M)
—
Beta
—
RSI (14D)
50.9
Price vs SMA 50
-3.1%
Price vs SMA 200
-10.9%
Avg volume (3M)
7,192
Relative volume
0.1
Average dollar volume
$3,225

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
22.90M

Valuation

12 metrics
P / E (TTM)
43.6
Trailing earnings · reciprocal yield 2.3%
PEG ratio
—
EV / revenue
0.3×
reciprocal yield 392.6%
EV / EBITDA
—
EV / EBIT
—
P / sales
1.2×
reciprocal yield 86.3%
P / book
1.1
reciprocal yield 95.0%
FCF yield
-3.8%
TTM · current market cap
Buyback yield
0.1%
P / FCF
—
P / operating cash flow
—
Earnings yield
2.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
0.3×
reciprocal yield 346.8%
EV / revenue historical average (5Y)
0.3×
reciprocal yield 345.8%
EV / EBIT historical average (3Y)
6.6×
reciprocal yield 15.2%
EV / EBIT historical average (5Y)
6.6×
reciprocal yield 15.2%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
15.6%
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
$0.08
Dividend growth YoY
+0.0%
Dividend growth streak
0
Last ex-dividend
2026-02-27

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
32.3%
Operating margin
-1.6%
Trailing 12 months
Net margin
2.7%
Gross profit (TTM)
$3.07M
Operating profit (TTM)
−$154,943
Net income (TTM)
$251,525
Trailing 12 months
Diluted EPS (TTM)
$0.01
FCF margin
-4.4%
Effective tax rate
6.5%

Per share

11 metrics
Revenue per diluted share (TTM)
$0.41
Gross profit per diluted share (TTM)
$0.13
Operating profit per diluted share (TTM)
$-0.01
EBITDA per diluted share (TTM)
$0.00
Net income per diluted share (TTM)
$0.01
Operating cash flow per diluted share (TTM)
$-0.02
Free cash flow per diluted share (TTM)
$-0.02
Capital expenditures per diluted share (TTM)
$0.00
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.00
Book value per share
$0.52

Growth

11 metrics
Revenue growth YoY
+19.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$9.48M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-0.1%
Year over year · fewer shares
Revenue CAGR (3Y)
-22.6%
Revenue CAGR (5Y)
-16.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
2.4%
Return on assets
2.2%
Debt / equity
0.0
Current ratio
11.3
EBITDA (TTM)
−$97,005
Free cash flow (TTM)
−$421,364
Quick ratio
11.3
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
-7.8%
Trailing 12 months
Net cash
$8.58M
Latest balance sheet
Cash & equivalents
$1.52M
Total assets
$11.44M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$414,892
Capital expenditures (TTM)
$6,472
R&D (TTM)
—
SG&A (TTM)
$3.22M
Stock compensation (TTM)
$30,257
R&D / revenue
—
Stock compensation / revenue
0.3%

Ownership (13F)

9 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
38 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—